This abstract, presented at the 2019 EHA Congress, reports on the effects of treatment with a novel DHODH inhibitor under investigation as a potential treatment for AML on cell lines in vitro
EHA 2019 Abstract: Inhibition of de novo pyrimidine nucleotide synthesis by the novel dihydroorotate dehydrogenase (DHODH) inhibitor PTC299 induces differentiation and/or death of acute myeloid leukemia (AML) cells
GL-CORP-0207 | June 2021
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.